|
 
Puregon®, recombinant follicle-stimulating hormone (FSH), is a pure gonadotropin widely used to treat infertility. The product was launched by Organon in 1996, the culmination of a 12-year research and development program.
In women a course of Puregon treatment will stimulate the development of follicles in the ovary. Prior to IVF (in vitro fertilization), the ovaries are stimulated by Puregon so that several follicles develop to produce eggs. These can then be collected for fertilization in the laboratory. In infertile men a course of Puregon is indicated to create sperm cells and/or increase their number.
 Puregon is available in various presentation forms, including vials, ampoules, and cartridges to use with a pen device. It can be administered at home, or in clinics by a nurse or doctor.
|
| |
|
|
